4//SEC Filing
Intersect ENT, Inc. 4
Accession 0001614476-15-000001
CIK 0001271214operating
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 5:36 PM ET
Size
9.1 KB
Accession
0001614476-15-000001
Insider Transaction Report
Form 4
Binney Robert H Jr
Vice President, Sales
Transactions
- Sale
Common Stock
2015-01-26$21.18/sh−6,300$133,460→ 4,352 total - Exercise/Conversion
Stock Option (right to buy)
2015-01-26−6,300→ 81,200 totalExercise: $1.08Exp: 2021-09-21→ Common Stock (6,300 underlying) - Exercise/Conversion
Common Stock
2015-01-26$1.08/sh+6,300$6,804→ 10,652 total
Footnotes (3)
- [F1]The sale in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2014.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.86 to $21.25, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The shares subject to the option are immediately exercisable. 25% of the shares subject to the option vested on July 18, 2012 and 1/48th of the shares subject to the option vests monthly thereafter over three (3) years.
Documents
Issuer
Intersect ENT, Inc.
CIK 0001271214
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001271214
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 5:36 PM ET
- Size
- 9.1 KB